1. What is the main purpose of USP General Chapter <800>?
A. Enforce OSHA and EPA standards concerning hazardous materials
B. Limit occupational exposure to hazardous drugs
C. Define engineering controls that must be used
D. Provide framework for Joint Commission standards
2. In USP General Chapter <800>, which of the following is considered a health care setting?
A. Manufacturing plant
B. Wholesaler facility
C. Community pharmacy
D. Patient's home
3. What document is the source for a list of hazardous drugs?
A. OSHA Technical Manual on Controlling Occupational Exposure to Hazardous Drugs
B. Joint Commission Medication Management Standards
C. CMS Conditions of Participation
D. NIOSH List of Antineoplastics and Other Hazardous Drugs in Healthcare Settings
4. What are the three types of hazardous drugs?
A. Antineoplastics, nonantineoplastics, reproductive-only hazards
B. Antineoplastics, immunosuppressants, reproductive-only hazards
C. Antineoplastics, oncolytics, immunosuppressants
D. Antineoplastics, toxins, reproductive-only hazards
5. Which of the following agents can be considered in an assessment of risk?
A. Mixing an intravenous admixture containing cyclophosphamide injection
B. Counting methotrexate tablets
C. Compounding a flutamide oral suspension
D. Drawing up a dose of methotrexate injection
6. To what specific level must an assessment of risk be completed?
A. The type of drug
B. The generic name of the drug
C. The brand name of the drug
D. The dosage form of the drug
7. Which of the following engineering controls are appropriate for use with hazardous drugs?
A. Powder containment hood, biological safety cabinet, and compounding aseptic containment isolator
B. Powder hood, laminar air flow workbench, and biological safety cabinet
C. Laminar air flow workbench, biological safety cabinet, and compounding aseptic containment isolator
D. Compounding aseptic isolator, compounding aseptic containment isolator, and biological safety cabinet
8. When must closed system drug-transfer devices be used?
A. Recommended for both compounding and administering
B. Required for both compounding and administering
C. Recommended for compounding; required for administering
D. Required for compounding; recommended for administering
9. What testing standard must gloves designed for protection against hazardous drugs meet?
A. ASTM D6978
B. ASTM F739
C. TJC MM.05.01.07
D. NABP Model Rules
10. What type of environmental monitoring is designed to detect hazardous drugs that have escaped contamination?
A. Gloved fingertip test
B. Viable surface sampling
C. Electronic air sampling
D. Wipe sampling
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. To what extent did the program meet objective #5?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
23. Will the information presented cause you to change your practice?
A. Yes
B. No
24. Are you committed to making these changes?
A. Yes
B. No
25. As a result of this activity, did you learn something new?
A. Yes
B. No
26. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
27. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20
E. >20
